Highnoon Laboratories Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Highnoon Laboratories has a total shareholder equity of PKR10.1B and total debt of PKR1.1B, which brings its debt-to-equity ratio to 11.1%. Its total assets and total liabilities are PKR14.9B and PKR4.8B respectively. Highnoon Laboratories's EBIT is PKR4.3B making its interest coverage ratio 24.5. It has cash and short-term investments of PKR2.4B.
Anahtar bilgiler
11.1%
Borç/özkaynak oranı
PK₨1.12b
Borç
| Faiz karşılama oranı | 24.5x |
| Nakit | PK₨2.40b |
| Eşitlik | PK₨10.05b |
| Toplam yükümlülükler | PK₨4.84b |
| Toplam varlıklar | PK₨14.89b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: HINOON's short term assets (PKR10.6B) exceed its short term liabilities (PKR3.3B).
Uzun Vadeli Yükümlülükler: HINOON's short term assets (PKR10.6B) exceed its long term liabilities (PKR1.5B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: HINOON has more cash than its total debt.
Borcun Azaltılması: HINOON's debt to equity ratio has increased from 1.5% to 11.1% over the past 5 years.
Borç Kapsamı: HINOON's debt is well covered by operating cash flow (324.4%).
Faiz Kapsamı: HINOON's interest payments on its debt are well covered by EBIT (24.5x coverage).